Literature DB >> 1720058

Relationship between alpha-fetoprotein serum levels, tumour volume and growth rate of hepatocellular carcinoma in a western population.

L Bolondi1, G Benzi, V Santi, S Gaiani, S L Li Bassi, G Zironi, A Mazziotti, C Sama, W Grigioni, G Gozzetti.   

Abstract

In order to detect a possible relationship between alpha-fetoprotein (AFP) levels, total tumour volume at the moment of the discovery and the tumour volume doubling time, we studied a population of 138 patients, affected by Hepatocellular Carcinoma (HCC) discovered at abdominal ultrasound (US) examination and confirmed by liver biopsy in all cases. In each patient the serum AFP level was determined within a week before or after the US examination. A small therapy-free subgroup of 23 patients, was also serially observed for a mean period of 4 months, so making possible the evaluation of the tumour volume doubling time and its relationship with the initial value of AFP. In 81 patients (58.7%) the serum AFP resulted less than 20 ngr/ml in 21 (15.2%), between 20 and 200 and in 36 (26.1%) greater than 200ngr/ml. No statistical correlation was found between the tumour volume calculated on the basis of the US image at the moment of the discovery and the AFP level, even though very high levels (greater than 3000) were found only in large tumours. Furthermore the tumour doubling time was not correlated with the initial value of AFP.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1720058

Source DB:  PubMed          Journal:  Ital J Gastroenterol        ISSN: 0392-0623


  6 in total

1.  Outcome of 67 patients with hepatocellular cancer detected during screening of 1125 patients with chronic hepatitis.

Authors:  F Izzo; F Cremona; F Ruffolo; R Palaia; V Parisi; S A Curley
Journal:  Ann Surg       Date:  1998-04       Impact factor: 12.969

Review 2.  Evidence Supporting LI-RADS Major Features for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review.

Authors:  An Tang; Mustafa R Bashir; Michael T Corwin; Irene Cruite; Christoph F Dietrich; Richard K G Do; Eric C Ehman; Kathryn J Fowler; Hero K Hussain; Reena C Jha; Adib R Karam; Adrija Mamidipalli; Robert M Marks; Donald G Mitchell; Tara A Morgan; Michael A Ohliger; Amol Shah; Kim-Nhien Vu; Claude B Sirlin
Journal:  Radiology       Date:  2017-11-21       Impact factor: 11.105

3.  Serological and histological indices of hepatocellular carcinoma and tumor volume doubling time.

Authors:  Naoki Shingaki; Hideyuki Tamai; Yoshiyuki Mori; Kosaku Moribata; Shotaro Enomoto; Hisanobu Deguchi; Kazuki Ueda; Izumi Inoue; Takao Maekita; Mikitaka Iguchi; Jun Kato; Masao Ichinose
Journal:  Mol Clin Oncol       Date:  2013-09-17

4.  Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.

Authors:  Agostino Colli; Tin Nadarevic; Damir Miletic; Vanja Giljaca; Mirella Fraquelli; Davor Štimac; Giovanni Casazza
Journal:  Cochrane Database Syst Rev       Date:  2021-04-15

5.  Microenvironment inflammatory infiltrate drives growth speed and outcome of hepatocellular carcinoma: a prospective clinical study.

Authors:  Rosina Critelli; Fabiola Milosa; Francesca Faillaci; Rosario Condello; Elena Turola; Luca Marzi; Barbara Lei; Francesco Dituri; Silvia Andreani; Pamela Sighinolfi; Paola Manni; Antonino Maiorana; Cristian Caporali; Fabrizio di Benedetto; Mariagrazia Del Buono; Nicola De Maria; Filippo Schepis; Maria-Luz Martinez-Chantar; Gianluigi Giannelli; Erica Villa
Journal:  Cell Death Dis       Date:  2017-08-24       Impact factor: 8.469

6.  The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis.

Authors:  Oscar Arrieta; Bernardo Cacho; Daniela Morales-Espinosa; Ana Ruelas-Villavicencio; Diana Flores-Estrada; Norma Hernández-Pedro
Journal:  BMC Cancer       Date:  2007-02-08       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.